Most of the bone metastases of prostate cancer are difficult to be cured, the survival rate of 5 years after active treatment is about 40%, and the survival rate of 10 years is less than 30%, and the specific situation varies from person to person.
Prostate cancer bone metastasis pain treatment medications include painkillers, radiotherapy and endocrine therapy, etc. The medications need to be used in a standardized way under the guidance of doctors.
Prostate cancer patients with bone metastasis indicate that it has entered the advanced stage, and its treatment mainly includes lesion-specific treatment and symptomatic treatment:
1. Treatment targeting the lesion:
Endocrine therapy is the main treatment for patients with hormone-dependent prostate cancer with bone metastasis; chemotherapy is one of the main treatments for hormone-resistant prostate cancer; molecular targeting therapy such as denosumab is an optional treatment; radiotherapy is valuable for relieving pain and treating metastatic foci and primary foci; and some patients can receive surgical treatment.
2. Symptomatic treatment:
Bisphosphonate phosphate, as the first-line drug for bone metastatic cancer, can effectively treat bone destruction and relieve bone pain; radiotherapy is also of great value in relieving bone pain; in addition, reasonable analgesic treatment is of great significance in improving the survival quality of patients.
Some studies say that the survival rate of prostate cancer combined with bone metastasis is about 80%, 70%, 42% and 30% in 1 year, 2 years, 5 years and 10 years, which is related to the staging, treatment, PSA level, patient’s age and other personal conditions.
It is recommended that patients go to the hospital in time and take specific treatment measures as prescribed by the doctor. Please strictly follow the doctor’s instructions for drug treatment, do not self-medicate.